Keywords: CK; cytokeratins; BC; breast cancer; HER-2; human epidermal growth factor receptor-2; RT-PCR; reverse transcription followed by polymerase chain reaction; BBD; benign breast diseases; TNM; Classification of Malignant Tumors; ER; estrogen receptor; SBR; Sc
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: AP-1; activator protein-1; Bax; Bcl-2-associated X protein; Bcl-2; B cell lymphoma-2; CCl4; carbon tetrachloride; COX-2; cyclooxigenase-2; EGF; epidermal growth factor; ELAM-1; endothelial leukocyte adhesion molecule-1; FGF; fibroblast growth factor; GnRH
Keywords: metastatic breast cancer; MBC; lobaplatin and gemcitabine; GL; lobaplatin and vinorelbine; NL; cisplatin and gemcitabine; GP; cisplatin and vinorelbine; NP; progression-free survival; PFS; overall survival; OS; response rate; RR; platinum-based compounds;
Keywords: Esophagus; Squamous cell carcinoma; Adenocarcinoma; Gastric carcinoma; Molecular genetics; HER-2; Trastuzumab; Next-generation sequencing;
Keywords: Ovarian cancer; EGFR; HER-2; c-MET; 3D cell culture; Targeted inhibitors; Ascites;
Keywords: ABC; Accelerated blood clearance; BBB; Blood brain barrier; CH; Cholesterol; CHEMS; Cholesteryl hemisuccinate; DOPE; 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine; DPPC; 1,2-dipalmitoyl-sn-glycero-3-phosphocholine; DPPG2; 1,2-dipalmitoyl-sn-glycero-3-phos
Keywords: Invasive lobular carcinoma; Patient age; Estrogen and progesterone receptors; HER-2; E-cadherin;
Keywords: Hepatitis B virus (HBV); Hepatitis C virus (HCV); Breast cancer; Chemotherapy; HBV/HCV reactivation; Toxicity; HCV; hepatitis C virus; CHC; chronic hepatitis C; HBV; hepatitis B virus; CHB; chronic hepatitis B; DAAs; direct-acting antiviral agents; ER; es
Keywords: Modified lymph node ratio; Breast cancer; Prognosis; Nomogram; LN; lymph nodes; LNR; lymph node ratio; mLNR; modified lymph node ratio; pN; pathologic positive lymph node; C-index; Concordance index; ALND; axillary lymph node dissection; IDC; invasive duc
Keywords: P-glycoprotein; Nanoparticle; Her-2; Aptamer; siRNA;
Keywords: VEGF; HER-2; Gastric cancer; Prognostic factor; Angiogenesis;
Keywords: AIF; Apoptosis-inducing factor; cDNA; complementary DNA; DIABLO; Direct IAP binding protein with low pI; EGF; Epidermal growth factor; GMCSF; Granulocyte Macrophage colony-stimulating factor; HER-2; Human epidermal growth factor receptor 2; IAP; Inhibitor
Keywords: Hypersensitivity reactions; Drug allergy; Anaphylaxis; Biological agents; Monoclonal antibodies; Tryptase; Epinephrine; Skin testing; Rapid desensitization; AS; Ankylosing spondylitis; ASA; Acetylsalicylic acid; BAT; Basophil activation test; CD; Crohn's
Keywords: Breast cancer; HER-2-negative; Resistance; Biologic targeted agent; Combination therapy; ABC; advanced breast cancer; AE; adverse event; AI; aromatase inhibitor; AKT; protein kinase; BC; breast cancer; CDK; cyclin-dependent kinase; CT; chemotherapy; CTLA;
Keywords: AuNPs; gold nanoparticles; AuNSs; gold nanoshells; AuNRs; gold nanorods; CTAB; cetyltrimethylammonium bromide; EPR; enhanced permeability and retention; RES; reticuloendothelial system; PEG; polyethylene glycol; NIR; near-infrared; TEM; transmission elect
Keywords: BSA; bovine serum albumin; E2; 17β-estradiol; ER; estrogen receptor; ERAB; estrogen receptor autoantibodies; ERαAB; estrogen receptor α autoantibodies; ERβAB; estrogen receptor β autoantibodies; ERK; extracellular signal-regulated kinase; GPR30; G pr
Keywords: HER-2; Resistance; Breast cancer;
Keywords: S/B; signal to background; PDGFR; platelet-derived growth factor receptor; BTK; Bruton's tyrosine kinase; EGFR; epidermal growth factor receptor; HER-2; human epidermal growth factor 2; AMPK; AMP activated protein kinase; BMPR; bone morphogenetic protei
Keywords: IGFs; insulin-like growth factors; SHBG; sex hormone binding globulin; BMI; body mass index; IGFBPs; IGF binding proteins; IGF-1R; insulin-like growth factor-1 receptor; CLS; crown-like structure; NFκB; nuclear factor kappa-B; STAT3; signal transducer an
Keywords: Epigenetics; Phytochemicals; DNA-methylation; Histone-modification; miRNA; Carcinogenesis; Akt; v-akt murine thymoma viral oncogene homolog 1; AP-1; Activator Protein-1; Bax; BCL2-associated X protein; Bcl2; B-cell CLL/lymphoma 2; Bcl-xL; B-cell lymphoma-
Functions and mechanisms of microRNA-31 in human cancers
Keywords: 3â²-UTRs3â²; -untranslated regions; ADC; Adenocarcinoma; BC; Breast cancer; BER; base excision repair; CDK4; cyclin-dependent kinase 4; CRC; Colorectal cancer; CRT; chemo-radiation therapy; C-TAD; COOH terminal transactivation domain; DHR1; dihydrorhoda
Discovery and evaluation of nNav1.5 sodium channel blockers with potent cell invasion inhibitory activity in breast cancer cells
Keywords: CDCl3; Deuterated chloroform; CH2Cl2; Methylene dichloride; 13C NMR; Carbon-13 nuclear magnetic resonance; CoMFA; Comparative molecular field analysis; CuBr.Me2S; Copper bromide dimethyl sulfide; DMEM; Dulbecco's modified eagle medium; DMSO; Dimethyl sulf
Design, synthesis and biological evaluation of pyrazolyl-thiazolinone derivatives as potential EGFR and HER-2 kinase inhibitors
Keywords: Pyrazolyl-thiazolidinone; EGFR; HER-2; Antitumor; Structure-activity relationship;
Epigenetics of breast cancer: Biology and clinical implication in the era of precision medicine
Keywords: BC; breast Cancer; ER; estrogen Receptor; PgR,PR; progesteron receptor; HER-2; human epidermal growth factor receptor 2; TNBC; triple negative breast cancer; ncRNA; non coding RNA; CpG(s); cytosine-phosphate-guanine dinucleotide(s); 5-me-C; 5-methyl-cytos
Biomimetic nano-surfactant stabilizes sub-50 nanometer phospholipid particles enabling high paclitaxel payload and deep tumor penetration
Keywords: Nano medicine; Drug delivery; Phospholipid; Liposomes; Fluid-gel transition; Surfactant; Micelle; Amphipathic peptides; Lipoproteins; Apolipoproteins; Paclitaxel; Breast cancer; Her-2;
Detection of HER-2 gene copy number variations as a molecular marker in the peripheral blood of women with endometriosis in Iranian population: Case-control study
Keywords: HER-2; human epidermal growth factor receptor 2; T1GFR; type 1 growth factor receptor; EDTA; ethylenediaminetetraacetic acid; Ct; threshold cycle; Biomarker; Copy number variation; Endometriosis; HER-2/neu; Iran; Real-time PCR;
Ginkgetin inhibits growth of breast carcinoma via regulating MAPKs pathway
Keywords: ER; estrogen receptor; GK; ginkgetin; Her-2; human epidermal growth factor receptor-2; MAPKs; mitogen-activated protein kinases; p-ERK; phospho extracellular-related kinase; p-JNK; phospho Jun-amino-terminal kinase; PR; progesterone receptor; MTT; 3-[4,5-
Synergistic effects of coralyne and paclitaxel on cell migration and proliferation of breast cancer cells lines
Keywords: CI; combinational index; Fa; fraction affected; ER; estrogen receptor; PR; progesterone receptor; Her-2; human epidermal growth factor receptor 2; Synergy; Coralyne; Cell proliferation; Cell migration; Apoptosis;
Sn- and Ge- triorganometallics exert different cytotoxicity and modulation of migration in triple-negative breast cancer cell line MDA-MB-231
Keywords: APL; acute promyelocytic leukemia; BSA; bovine serum albumin; DHA; docosahexaenoic acid; DMSO; dimethylsulfoxide; ER; estrogen receptor; FDA; fluorescein diacetate; FCS; fetal calf serum; FITC; fluorescein isothiocyanate; HER-2; human epidermal growth fac
Neoadjuvant systemic therapy in breast cancer: Challenges and uncertainties
Keywords: Neoadjuvant therapy; Breast cancer; Survival; Targeted; Therapy; HER-2; Treatment; Biology; Chemotherapy;
New bis(hydroxymethyl) alkanoate curcuminoid derivatives exhibit activity against triple-negative breast cancer in vitro and in vivo
Keywords: Antiproliferative agents; Antitumor agents; Bis(hydroxymethyl) alkanoate curcuminoids; Curcumin; Triple-negative breast cancer; BUN; blood urea nitrogen; DMAP; N,N-dimethylaminopyridine; DMF; dimethylformamide; DMSO; dimethylsulfoxide; EtOAc; ethyl acetat
Focused ultrasound induced hyperthermia accelerates and increases the uptake of anti-HER-2 antibodies in a xenograft model
Keywords: DPBS; Dulbecco's Phosphate-Buffered Saline; DMSO; dimethyl sulfoxide; EGFR; Epidermal Growth Factor receptor; FDA; U S Food and Drug Administration; FUS; Focused Ultrasound; HER-2; Human Epidermal Growth Factor receptor 2; HIFU; High Intensity Ultrasoun
Collagen fibers mediate MRI-detected water diffusion and anisotropy in breast cancers
Keywords: 2D; two-dimensional; 3D; three-dimensional; aDW; average diffusion weighted; ADC; apparent diffusion coefficient; Col1; collagen 1; DTI; diffusion tensor imaging; ECM; extracellular matrix; ER; estrogen receptor; FA; fractional anisotropy; FOV; field of v
Gene expression profiling and DNA methylation analyses of CTCs
Keywords: Circulating Tumor Cells; CTCs; Molecular assays; Multiplex RT-PCR; Molecular characterization; Quantitative PCR (qPCR); Reverse transcription PCR; RT-qPCR; Methylation specific PCR; Gene expression; aCGH; array-comparative genomic hybridization; BRMS1; Br
Exploring miRNA based approaches in cancer diagnostics and therapeutics
Keywords: miRNA; microRNA; TRBP; Transactivating Response RNA-Binding Protein; RISC; RNA induced silencing complex; UTR; untranslated region; DDX; DEAD box protein; TS; tumor suppressor; OG; oncogene; TGF β; Transforming Growth Factor β; RT-PCR; Real Time-polymer
HER-2, ER, PR status concordance in primary breast cancer and corresponding metastatic lesion in lymph node in Chinese women
Keywords: ER; PR; HER-2; Breast cancer; Metastatic lymph nodes;
Aptamers as smart ligands for nano-carriers targeting
Keywords: Aptamer; Targeting; Nano-carriers; Cancer therapy; Affinity ligand; 225Ac; Actinium isotope 225; Bcl-xl; B-cell lymphoma-extra large transmembrane protein; CD; Cluster of differentiation; CNTs; Carbon nanotubes; CTLA 4; cytotoxic T-lymphocyte-associated p
High co-expression of Sp1 and HER-2 is correlated with poor prognosis of gastric cancer patients
Keywords: HER-2; Sp1; Gastric cancer; Immunohistochemistry; Prognosis
Synthesis and stability test of radiogadolinium(III)-DOTA-PAMAM G3.0-trastuzumab as SPECT-MRI molecular imaging agent for diagnosis of HER-2 positive breast cancer
Keywords: Gd-DOTA-PAMAM G3.0-trastuzumab; HER-2; Target-specific radiopharmaceutical; Targeted contrast agent
Targeting HER-2 over expressed breast cancer cells with 2-cyclohexyl-N-[(Z)-(substituted phenyl/furan-2-yl/thiophene-2-yl)methylidene]hydrazinecarbothioamide
Keywords: Thiosemicarbazones; Antitumor activity; Breast cancer; HER-2;
Synthesis, physicochemical and biological evaluation of technetium-99m labeled lapatinib as a novel potential tumor imaging agent of Her-2 positive breast cancer
Keywords: Lapatinib; Her-2 receptor; Technetium; Radiopharmaceutical; SKOV-3; Her-2; Human Epidermal Growth Factor Receptor 2; IHC; immunohistochemical; FISH; fluorescent in situ hybridisation; CISH; chromogenic in situ hybridisation; HPLC; high-performance liquid
Prognostic implications of lobular breast cancer histology: New insights from a single hospital cross-sectional study and SEER data
Keywords: Breast cancer; Ductal; Histology; Lobular; Prognosis; ILC; invasive lobular breast cancer; IDC; invasive ductal breast cancer; SEER; Surveillance Epidemiology End Results; ER; estrogen receptor; PR; progesteron receptor; HER-2; human epidermal growth fact
Gene delivery to Her-2Â + breast cancer cells using a two-component delivery system to achieve specificity
Keywords: Gene therapy; Cancer treatment; Liposome; Polylysine; Listeriolysin O; Her-2; Erbb-2;
X-ray CT guided fault-free photothermal ablation of metastatic lymph nodes with ultrafine HER-2 targeting W18O49 nanoparticles
Keywords: Nanoparticles; Computed tomography; Tungsten oxide; Metastasis; Photothermal therapy; HER-2
LGR5 is a biomarker for stratification of HER-2 positive breast cancer patients and personalized treatment
Keywords: AKT; v-akt murine thymoma viral oncogene; CTNNB1; catenin (cadherin-associated protein), beta 1; HER-2; v-erb-b2 erythroblastic leukemia viral oncogene homolog 2; IgG1; immunoglobulin G 1; LGR5; leucine-rich repeat containing G protein-coupled receptor 5;
A phase II study of lapatinib, a dual EGFR and HER-2 tyrosine kinase inhibitor, in patients with castration-resistant prostate cancer
Keywords: Castration-resistant prostate cancer; Targeted therapy; Tyrosine kinase; Epidermal growth factor receptor; HER-2; Lapatinib
Molecular Diagnostics in Esophageal and Gastric Neoplasms
Keywords: Esophagus; Squamous cell carcinoma; Adenocarcinoma; Gastric carcinoma; Molecular genetics; HER-2; Trastuzumab;
HER-2 expression in canine morphologically normal, hyperplastic and neoplastic mammary tissues and its correlation with the clinical outcome
Keywords: Dog; HER-2; Immunohistochemistry; Mammary tumours; Overall-survival; Prognosis
Synthesis, molecular docking and evaluation of thiazolyl-pyrazoline derivatives containing benzodioxole as potential anticancer agents
Keywords: Benzodioxole; Thiazole; Pyrazoline; HER-2
Discovery of a potent dual EGFR/HER-2 inhibitor L-2 (selatinib) for the treatment of cancer
Keywords: EGFR; HER-2; Lapatinib analogs; NCI-N87; SK-OV-3; Selatinib